Content is available to registered users only. Registration is free.
Register now, or if you’ve already registered, log in.
Jason Wermers, CRTonline.org
The Symplicity Spyral Renal Denervation System received marketing approval from the U.S. Food and Drug Administration (FDA) to treat hypertension, Medtronic announced Friday.
CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.